Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
2 Choose your treatment option Select your preferred option
Merck beat AstraZeneca to market, whose rival oral PCSK9 (AZD0780) is still in development a real head start on payer contracts and prescriber habits
To control for multiple comparisons across timepoints, networks or subcortical structures, FDR correction was applied
None of the RCTs enrolled patients with ESA hyporesponsiveness, and only 1 enrolled patients with functional iron deficiency 214
US$ 27.56
US$ 29.05
US$ 29.91
US$ 28.88
US$ 29.95
US$ 25.97
US$ 25.46
US$ 22.09
US$ 29.40
US$ 20.67
